IMMUNOCHINA
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.
IMMUNOCHINA
Social Links:
Industry:
Biotechnology Clinical Trials Medical Medical Device Pharmaceutical
Founded:
2015-04-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.immunochina.com
Total Employee:
1+
Status:
Active
Contact:
010-62886890
Email Addresses:
[email protected]
Total Funding:
28.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network JsDelivr PHP ASP.NET Apple Mobile Web App Capable IIS Apple Mobile Web App Status Bar Style OSS CDN
Similar Organizations
Genetron Health
Genetron Health is a world-leading expert in precision medicine.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Employees Featured
Founder
Investors List
GF Qianhe Investment
GF Qianhe Investment investment in Series D - Immunochina
Yajie Shanghui
Yajie Shanghui investment in Series D - Immunochina
China Life Private Equity Investment
China Life Private Equity Investment investment in Series D - Immunochina
SDIC Venture Capital
SDIC Venture Capital investment in Series D - Immunochina
China-Belgium Direct Equity Investment Fund
China-Belgium Direct Equity Investment Fund investment in Series C - Immunochina
Sherpa Venture Capital
Sherpa Venture Capital investment in Series C - Immunochina
Shougang Fund
Shougang Fund investment in Series C - Immunochina
Peter Thiel
Peter Thiel investment in Series C - Immunochina
Qingzhe Capital
Qingzhe Capital investment in Series C - Immunochina
Legend Capital
Legend Capital investment in Series B - Immunochina
Official Site Inspections
http://www.immunochina.com
- Host name: 120.25.154.4
- IP address: 120.25.154.4
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Immunochina"
Immunochina - Crunchbase Company Profile & Funding
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina …See details»
艺妙神州 - immunochina.com
Immunochina’s CD19 CAR-T joins hands with Lu Daopei Hospital to shine at the 44th European Society of Blood and Marrow Transplantation Annual Meeting. 2017-11-23. Immunochina …See details»
艺妙神州_致力于将创新的基因细胞药物技术应用于恶性肿瘤治疗
艺妙神州，北京艺妙神州医药科技有限公司，北京艺妙神州医疗科技有限公司，car-t，何霆，自体car-t，通用型car-t，异体car-t，实体瘤，血液瘤，免疫治疗，ind，新药临床试验批件，注册临 …See details»
Imunopharm - Products, Competitors, Financials, Employees, …
Imunopharm was formerly known as Immunochina. It was founded in 2015 and is based in Beijing, Beijing. Headquarters Location. B1 District, Yiyuan Cultural and Creative Industry …See details»
Immunochina Pharmaceuticals - PitchBook
Immunochina Pharmaceuticals General Information Description. Developer of gene cell medicine technology intended for malignant tumor treatment. The company is devoted to the …See details»
Immunochina Company Profile - Office Locations, Competitors
Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. It provides treatments for a variety of malignant …See details»
Immunochina - Org Chart, Teams, Culture & Jobs - The Org
View Immunochina's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Immunochina - Overview, News & Similar companies - ZoomInfo
Immunochina contact info: Phone number: +86 1062886890 Website: www.immunochina.com What does Immunochina do? Immunochina is a company that operates in the Biotechnology …See details»
Immunochina - CoBee Company Profile & Funding Rounds
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also …See details»
Immunochina Pharmaceuticals - Golden
Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy. Overview Structured Data Issues Contributors Activity. …See details»
Immunochina - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Beijing Imunopharm Technology Co., Ltd. - Drug pipelines, Patents ...
Dec 28, 2024 Anti-GUCY2C chimeric antigen receptor T-cell (Immunochina) Target. GC-C. Mechanism. GC-C antagonists [+2] Active Org. Beijing Yimiao Medical Technology Co., Ltd. …See details»
Immunochina - VentureRadar
"ImmunoPharma is committed to applying innovative gene cell drug technology to the treatment of malignant tumors. The company focuses on developing and promoting advanced …See details»
Immunochina - Contacts, Employees, Board Members, Advisors
Organization. Immunochina . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Immunochina …See details»
Immunochina (China) Funding: $45.2M - Medical Startups
Nov 26, 2024 Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell...See details»
Immunochina won the "2019 China Top 50 Healthcare Innovation …
Immunochina won the "2019 China Top 50 Healthcare Innovation Enterprises" 2019年9月18日，由创业邦主办的“2019 Demo China 创新中国未来科技节”在杭州开幕，本次峰会以 “硬核时 …See details»
Beijing Immunochina Closes Series D+ with at least $28 Million for …
Nov 2, 2022 Beijing Immunochina raised at least $28 million in a Series D+ round of to support the NDA filing and commercialization of its lead product, CAR-T IM19. The IM19 molecule, a …See details»
Immunochina raises $20M for blood cancer CAR-T - Fierce Biotech
Jan 22, 2019 Immunochina is targeting China’s domestic market to begin with, but co-founder and CEO Ting He, Ph.D., is frank about the biotech’s aspiration to become an international …See details»
资讯中心 - immunochina.com
Immunochina and Edigene announce that they will jointly develop an allogeneic CAR-T therapy for cancer 05-272020 Learn More Immunochina obtained approval of clinical trial for IM19 …See details»
临床试验 - immunochina.com
Immunochina will endeavor and provide the high-quality service to assist each patient to fight cancer. We sincerely wish all patients a speedy and sound recovery. Subject Recruitment. …See details»